Evidence map›Paper›PMID 42149250›Full record

ReviewPlant cell reports2026

From pollen precursor to totipotent embryo: a model system for plant cell developmental plasticity.

Behzad Ahmadi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Behzad AhmadiDepartment of Maize and Forage Crops Research, Seed and Plant Improvement Institute (SPII), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. Behzad.ahmadi1987@gmail.com.ORCID http://orcid.org/0000-0001-6523-8667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Androgenesis, the stress-induced reprogramming of microspores into doubled haploid plants, remains a pivotal yet persistent constraint in contemporary plant breeding programs. During this dramatic fate re-specification, committed gametophytic cells regain totipotency, which is controlled by a complex signaling network that converts external stress signals into an organized developmental program. Stress-induced reactive oxygen species (ROS) function as secondary messengers, whose signaling capacity is unlocked by a robust antioxidant system that maintains redox homeostasis. Subsequently, triggered programmed cell death (PCD), through apoptotic and autophagic pathways, executes a selective dismantling of compromised microspores and mediates extensive cytoplasmic clearance. This internal reprogramming is complemented by extracellular modifications, including dynamic cell wall remodeling that enhances cellular plasticity, and the establishment of embryonic polarity via auxin gradient establishment. Together, these pathways-ROS signaling, controlled PCD, cell wall dynamism, and auxin-driven patterning-constitute a regulatory circuit that authorizes the switch from gametophytic to sporophytic identity. Elucidating the integrated signaling network that reprograms microspores into embryos enables the rational design of interventions to unlock embryogenic potential across recalcitrant genotypes. This foundational knowledge is essential for engineering robust, genotype-independent protocols to accelerate trait fixation, genome editing, and cultivar development.

Indexed as

Cell PlasticityPlant CellsPollenSeedsTotipotent Stem CellsCell WallIndoleacetic AcidsModels, BiologicalReactive Oxygen SpeciesSignal TransductionIndoleacetic AcidsReactive Oxygen SpeciesAuxinCalloseCell wall remodelingEmbryoProgrammed cell deathReactive oxygen species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.